BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Debecarasib readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Debecarasib\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06586515-2602@assetmemo.bio
DTSTAMP:20261121T004541Z
DTSTART;VALUE=DATE:20280331
DTEND;VALUE=DATE:20280401
SUMMARY:Debecarasib: Phase 1 readout est. (NCT06586515)
DESCRIPTION:Debecarasib\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: MOO
 NRAY-01\, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid
  Tumors\nEstimated primary completion: March 2028. This is a ClinicalTrial
 s.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pag
 e: https://assetmemo.bio/drug/debecarasib#upcoming-events\nRegistry record
 : https://clinicaltrials.gov/study/NCT06586515
URL:https://assetmemo.bio/drug/debecarasib#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
